| 181/883 | US=23-F / Câncer Park SB, Kiernan MC. Chemotherapy-induced neurotoxicity. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 99-119. ISBN 978-90-481-3185-3. |
| 182/883 | US=23-F / Câncer Yague E, Raguz S. Multidrug resistance. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 121-33. ISBN 978-90-481-3185-3. RESISTENCIA A MULTIPLAS DROGAS; QUIMIOTERAPIA TRADICIONAL; CANCER DE CELULAS-TRONCO. RESISTENCIA AS DROGAS |
| 183/883 | US=26-A / Radioterapia Ang KK. Advances in the treatment of head and neck cancer. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 161-8. ISBN 978-0-323-04971-9. CANCER DE CABECA E PESCOCO; RADIOTERAPIA; QUIMIOTERAPIA; BIOMARCADORES MOLECULARES |
| 184/883 | US=23-F / Câncer Albrecht H. Role of antibodies in cancer treatment (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 135-52. ISBN 978-90-481-3185-3. |
| 185/883 | US=23-F / Câncer Lee W, Lockhart AC. Incorporating pharmacogenomics into cancer therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 153-72. ISBN 978-90-481-3185-3. |
| 186/883 | US=23-F / Câncer Morii E, Aozasa K. Cancer stem cells: an overview. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 173-81. ISBN 978-90-481-3185-3. CANCER DE CELULAS-TRONCO; ISOLAMENTO DO CANCE DE CELULAS-TRONCO |
| 187/883 | US=23-F / Câncer Mehta JP, O'Driscoll L, Barron N, Clynes M, Doolan P. Translating in vitro cell lines result into clinical practice. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 183-91. ISBN 978-90-481-3185-3. |
| 188/883 | US=23-F / Câncer Pellegrini P, Contasts AM, Berghella AM, Del Beato T. Adorno D. Classification of cancer stange using patient's Immune system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 195-213. ISBN 978-90-481-3185-3. CLASSIFICACAO DE CANCER; SISTEMA IMUNITARIO DO PACIENTE COM CANCER |
| 189/883 | US=23-F / Câncer Oldenburg J, Fossa SD. Late relapse of germ cell malignancies: incidence, management, and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 215-26. ISBN 978-90-481-3185-3. RECAIDA TARDIA DE TUMORES MALIGNOS DE CELULAS GERMINATIVAS; TUMORES MALIGNOS DE CELULAS GERMINATIVAS. PROGNOSTICO |
| 190/883 | US=23-F / Câncer Stack Jr BC, Clarke B, McElderry J, Dai Y, Ye JH. Head and neck squamous cell carcinoma: therapy with fusaric acid/paclitaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 229-35. ISBN 978-90-481-3185-3. CARCINOMA DE CELULAS ESCAMOSAS; TERAPIA COM ACIDO FUSARICO / PACLITAXEL |
| 191/883 | US=23-F / Câncer Shah NG, Trivedi TI. Early stage oral squamous cell carcinoma: use of signal transducer and activator of transcription 3 as a risk factor for poor diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 237-53. ISBN 978-90-481-3185-3. CARCINOMA DE CELULAS ESCAMOSAS ORAL; USO DE TRANSDUTOR DE SINAL; FATOR 3 ATIVADOR DA TRANSCRICAO |
| 192/883 | US=23-F / Câncer Nakamura T, Sumi M, Cauteren MV. Salivary gland tumors: preoperative tissue characterization with apparent diffusion coefficient mapping. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 255-69. ISBN 978-90-481-3185-3. TUMORES DAS GLANDULAS SALIVARES; TECIDUAL PRE-OPERATORIO COM MAPEAMENTO |
| 193/883 | US=23-F / Câncer Munck-Wikland E, Hammarstedt L, Dahlstrand H. Role of human papillomavirus in tonsillar cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 271-83. ISBN 978-90-481-3185-3. CANCER TOSILLAR; PAPILOMAVIRUS HUMANO; PAPEL NA CARCINOGENESE; CARCINOMA TONSILAR |
| 194/883 | US=23-F / Câncer Zhou X, Yu T, Wong DT. Quantitative reverse transcription - polymerase chain reaction based assessment of the canadidate biomarkers for tongue cancer metastasis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 285-302. ISBN 978-90-481-3185-3. BIOMARCADORES CANADIDATE; CANCER DA LINGUA; TRANSCRICAO REVERSA QUANTITATIVA |
| 195/883 | US=23-F / Câncer Li L, Liu LZ. Nasopharyngeal carcinoma (retropharyngeal lymph node metastasis): spread pattern, prognosis, and staging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 303-17. ISBN 978-90-481-3185-3. CARCINOMA DA NASOFARINGE; METASTASE RETROFARINGEO LINFATICOS; CARCINOMA DA NASOFARINGE. PROGNOSTICO; CARCINOMA DA NASOFARINGE. ESTADIAMENTO |
| 196/883 | US=23-F / Câncer Balmer A, Munier F, Zografos L. Retinoblastoma: diagnosis, treatment and prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 319-36. ISBN 978-90-481-3185-3. RETINOBLASTOMA; RETINOBLASTOMA. DIAGNOSTICO; RETINOBLASTOMA. PROGNOSTICO; RETINOBLASTOMA. TRATAMENTO |
| 197/883 | US=23-F / Câncer King D, Bodenner D, Strack Jr BC. Molecular genetics of thyroid cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 341-52. ISBN 978-90-481-3185-3. CANCER DE TIREOIDE; GENETICA MOLECULAR DO CANCER DE TIREOIDE |
| 198/883 | US=23-F / Câncer Griffith OL, Melck A, Jones SJM, Wiseman SM. Thyroid cancer: identification of expression markers for diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 353-77. ISBN 978-90-481-3185-3. |
| 199/883 | US=23-F / Câncer Nasr MR, Mukhopadhyay S. Papillary thyroid carcinoma: use of HBME1 and CK19 as diagnostic markers. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 379-85. ISBN 978-90-481-3185-3. CARCINOMA PAPILIFERO DE TIREOIDE; HBME1; CK19; CARCINOMA PAPILIFERO DA TIREOIDE; LESOES BENIGNAS DA TIREOIDE |
| 200/883 | US=23-F / Câncer Finn SP, O'Leary JJ, Sheils OM. Papillary thyroid carcinoma: detection of copy gain of platelet derived growth factor B using array combination with laser capture microdissection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 387-98. ISBN 978-90-481-3185-3. |